SEC Form 4 · accession 0001209191-17-011574
CELGENE CORP /DE/ · CELG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Hugin
Officer — see remarks · Director
Period of report
Feb 14, 2017
Accepted (ET)
Feb 16, 2017 · 5:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816284
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF3,F1,F2 | — | Feb 14, 2017 | A | 28,510 | A | — | — | Common Stock | 28,510 | 28,510 | D |
Explanation of responses
- F1Each share of phantom stock represents a right to receive one share of common stock.
- F2The phantom stock becomes payable six months following the reporting person's termination of employment with Celgene Corporation.
- F3The reporting person was awarded 28,510 shares of common stock pursuant to the 2014-2016 Long Term Incentive Plan under the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015). The reporting person deferred the receipt of such 28,510 shares of common stock and received instead 28,510 shares of phantom stock pursuant to the Celgene Corporation 2005 Deferred Compensation Plan.
Remarks
Executive Chairman